⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
PADCEV ™ + Keytruda ® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
businesswire.com
PFE
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
globenewswire.com
MDBH
LLY
NVO
PFE
AZN
GILD
GPCR
Bayer’s XOFIGO ® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases
businesswire.com
PFE
The International Myeloma Foundation Invites the Myeloma Community to Demonstrate the Spirit of #MoreThanMyeloma for 2026 Myeloma Action Month
globenewswire.com
GSK
JNJ
PFE
REGN
SNY
AMTX
ATHA
TMO
GILD
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing
businesswire.com
PFE
GSK
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
businesswire.com
PFE
GSK
Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036
globenewswire.com
ABBV
ALC
APLS
BHC
JNJ
PFE
REGN
TEVA
VTRS
Pharma is Losing $250 Billion to Patient Dropout. Here's How to Stop It.
prnewswire.com
PFE
Health and Wellness Product Market Growth 2026-2036: Global Market to Reach USD 18.5 Billion by 2036 at 8.2% CAGR
accessnewswire.com
KO
KHC
PG
PFE
U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer
businesswire.com
PFE